{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:50Z","timestamp":1787067890601,"version":"build-2736575974"},"reference-count":66,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00434","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T23:36:12Z","timestamp":1492040172000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Xiaohai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Reinsmoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.trre.2008.08.004","article-title":"Antibody-mediated rejection: treatment alternatives and outcomes","volume":"23","author":"Singh","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2016.10.016","article-title":"Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"B3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/tri.12887","article-title":"De novo donorspecific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability","volume":"30","author":"Kauke","year":"2016","journal-title":"Transpl Int"},{"issue":"4","key":"B4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.trre.2016.06.001","article-title":"Clinical value of non-HLA antibodies in kidney transplantation: still an enigma?","volume":"30","author":"Michielsen","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"issue":"10","key":"B5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","article-title":"HLA and MICA: targets of antibody-mediated rejection in heart transplantation","volume":"91","author":"Zhang","year":"2011","journal-title":"Transplantation"},{"issue":"11","key":"B6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1600-6143.2009.02819.x","article-title":"Effect of antibodies on endothelium","volume":"9","author":"Zhang","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12328","article-title":"Genetics, genomics, and evolutionary biology of NKG2D ligands","volume":"267","author":"Carapito","year":"2015","journal-title":"Immunol Rev"},{"issue":"6","key":"B8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1681\/ASN.2012080814","article-title":"MICA variant promotes allosensitization after kidney transplantation","volume":"24","author":"Tonnerre","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"B9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"issue":"13","key":"B10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"B11","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1111\/j.1600-6143.2007.01838.x","article-title":"The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection","volume":"7","author":"Suarez-Alvarez","year":"2007","journal-title":"Am J Transplant"},{"issue":"12","key":"B12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.humimm.2010.09.012","article-title":"Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation","volume":"71","author":"Nath","year":"2010","journal-title":"Hum Immunol"},{"issue":"6","key":"B13","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1074\/jbc.M111.282152","article-title":"NF-kappaB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site","volume":"287","author":"Lin","year":"2012","journal-title":"J Biol Chem"},{"issue":"7","key":"B14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J Clin Invest"},{"issue":"1","key":"B15","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"B16","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"25","key":"B17","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"B19","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"B20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"issue":"9","key":"B21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"issue":"10","key":"B22","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1097\/TP.0b013e318234b337","article-title":"Accelerated kidney transplant rejection and hypertensive encephalopathy in a pediatric patient associated with antibodies against angiotensin type 1 receptor and HLA class II","volume":"92","author":"Kelsch","year":"2011","journal-title":"Transplantation"},{"issue":"11","key":"B23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/TP.0b013e31816f612a","article-title":"Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies","volume":"85","author":"Amico","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"B24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.vph.2014.11.001","article-title":"Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects","volume":"63","author":"Vinturache","year":"2014","journal-title":"Vascul Pharmacol"},{"issue":"49","key":"B25","doi-asserted-by":"publisher","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","article-title":"Structural basis for ligand recognition and functional selectivity at angiotensin receptor","volume":"290","author":"Zhang","year":"2015","journal-title":"J Biol Chem"},{"issue":"4","key":"B26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","article-title":"Structure of the angiotensin receptor revealed by serial femtosecond crystallography","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00467-016-3500-8","article-title":"Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient","volume":"32","author":"Guzzo","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv375","article-title":"The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation","author":"Lee","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"B29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/nep.12441","article-title":"C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies","volume":"20","author":"Fuss","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"B30","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/TP.0000000000001231","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies","volume":"101","author":"Philogene","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"B31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jcjd.2015.08.016","article-title":"The role of renin angiotensin aldosterone system genes in diabetic nephropathy","volume":"40","author":"Rahimi","year":"2016","journal-title":"Can J Diabetes"},{"issue":"1","key":"B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/VHRM.S3121","article-title":"Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study","volume":"5","author":"Bichu","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"11","key":"B33","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.humimm.2013.06.006","article-title":"Role of anti-vimentin antibodies in allograft rejection","volume":"74","author":"Rose","year":"2013","journal-title":"Hum Immunol"},{"issue":"1","key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ncb898","article-title":"Vimentin is secreted by activated macrophages","volume":"5","author":"Mor-Vaknin","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"5","key":"B35","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","article-title":"The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis","volume":"50","author":"Van Steendam","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"B36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2478\/s11536-012-0131-8","article-title":"Vimentin cleavage in end-stage renal disease is not related to apoptosis","volume":"8","author":"Liebscher","year":"2013","journal-title":"Cent Eur J Med"},{"issue":"1","key":"B37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/01.TP.0000443224.66960.37","article-title":"Role of anti-vimentin antibodies in renal transplantation","volume":"98","author":"Besarani","year":"2014","journal-title":"Transplantation"},{"issue":"7","key":"B38","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"issue":"8","key":"B39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ctr.12567","article-title":"Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population","volume":"29","author":"Young","year":"2015","journal-title":"Clin Transplant"},{"issue":"4","key":"B40","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1172\/JCI44583","article-title":"Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans","volume":"121","author":"Lv","year":"2011","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.05.004","article-title":"The heart of the matter: protection of the myocardium from T cells","volume":"45","author":"Lichtman","year":"2013","journal-title":"J Autoimmun"},{"issue":"2","key":"B42","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.4049\/jimmunol.1004195","article-title":"Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients","volume":"187","author":"Kalache","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"B43","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.healun.2010.05.025","article-title":"Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy","volume":"29","author":"Nath","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"B44","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/ar.22973","article-title":"Structural implications of beta-cardiac myosin heavy chain mutations in human disease","volume":"297","author":"Colegrave","year":"2014","journal-title":"Anat Rec (Hoboken)"},{"issue":"11","key":"B45","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/TP.0b013e318218415d","article-title":"Autoimmune sensitization to cardiac myosin leads to acute rejection of cardiac allografts in miniature swine","volume":"91","author":"Veillette","year":"2011","journal-title":"Transplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.matbio.2013.08.004","article-title":"Border patrol: insights into the unique role of perlecan\/heparan sulfate proteoglycan 2 at cell and tissue borders","volume":"34","author":"Farach-Carson","year":"2014","journal-title":"Matrix Biol"},{"issue":"5","key":"B47","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.ajpath.2013.07.030","article-title":"Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction","volume":"183","author":"Katta","year":"2013","journal-title":"Am J Pathol"},{"issue":"5","key":"B48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/ajt.13119","article-title":"The perlecan fragment LG3 regulates homing of mesenchymal stem cells and neointima formation during vascular rejection","volume":"15","author":"Pilon","year":"2015","journal-title":"Am J Transplant"},{"issue":"1","key":"B49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/CIRCRESAHA.111.250431","article-title":"The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection","volume":"110","author":"Soulez","year":"2012","journal-title":"Circ Res"},{"issue":"318","key":"B50","doi-asserted-by":"publisher","first-page":"318ra200","DOI":"10.1126\/scitranslmed.aac9816","article-title":"The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection","volume":"7","author":"Dieude","year":"2015","journal-title":"Sci Transl Med"},{"issue":"4","key":"B51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/ajt.12168","article-title":"Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury","volume":"13","author":"Cardinal","year":"2013","journal-title":"Am J Transplant"},{"issue":"4","key":"B52","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0002-9440(10)62557-6","article-title":"Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat","volume":"160","author":"Joosten","year":"2002","journal-title":"Am J Pathol"},{"issue":"12","key":"B53","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1111\/ajt.13866","article-title":"Anti-LG3 antibodies aggravate renal ischemia-reperfusion injury and long-term renal allograft dysfunction","volume":"16","author":"Yang","year":"2016","journal-title":"Am J Transplant"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-016-9535-4","article-title":"The role of endoglin in post-ischemic revascularization","volume":"20","author":"Nunez-Gomez","year":"2017","journal-title":"Angiogenesis"},{"issue":"7","key":"B55","doi-asserted-by":"publisher","first-page":"10931","DOI":"10.18632\/oncotarget.14539","article-title":"FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors","volume":"8","author":"Nguyen","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"B56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.leukres.2015.10.009","article-title":"Potential role of FLT3-ligand in the angiogenic process of multiple myeloma","volume":"39","author":"Kokonozaki","year":"2015","journal-title":"Leuk Res"},{"issue":"5904","key":"B57","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1126\/science.1165218","article-title":"Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment","volume":"322","author":"Choi","year":"2008","journal-title":"Science"},{"issue":"1\u20132","key":"B58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tracli.2006.02.022","article-title":"LW protein: a promiscuous integrin receptor activated by adrenergic signaling","volume":"13","author":"Delahunty","year":"2006","journal-title":"Transfus Clin Biol"},{"issue":"5","key":"B59","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1681\/ASN.2013121277","article-title":"Endothelial cell antibodies associated with novel targets and increased rejection","volume":"26","author":"Jackson","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"B60","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00380-015-0666-0","article-title":"Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection","volume":"31","author":"Lehle","year":"2016","journal-title":"Heart Vessels"},{"issue":"2","key":"B61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies \u2013 quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"B62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/CS20160421","article-title":"Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation","volume":"131","author":"Yung","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"B63","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/ajt.12763","article-title":"Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss","volume":"14","author":"Gao","year":"2014","journal-title":"Am J Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"CD002922","DOI":"10.1002\/14651858.CD002922.pub3","article-title":"Treatment for lupus nephritis","volume":"12","author":"Henderson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"B65","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"B66","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T23:36:12Z","timestamp":1492040172000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":66,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00434","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}